0001739614-24-000011.txt : 20240312
0001739614-24-000011.hdr.sgml : 20240312
20240312162041
ACCESSION NUMBER: 0001739614-24-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240308
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deck Kelly
CENTRAL INDEX KEY: 0001819427
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39452
FILM NUMBER: 24742358
MAIL ADDRESS:
STREET 1: C/O INHIBRX, INC.
STREET 2: 11099 N. TORREY PINES ROAD, SUITE 280
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibrx, Inc.
CENTRAL INDEX KEY: 0001739614
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 824257312
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 795-4220
MAIL ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
wk-form4_1710274821.xml
FORM 4
X0508
4
2024-03-08
0
0001739614
Inhibrx, Inc.
INBX
0001819427
Deck Kelly
C/O INHIBRX, INC.
11025 NORTH TORREY PINES ROAD, SUITE 200
LA JOLLA
CA
92037
0
1
0
0
Chief Financial Officer
0
Stock Option (right to buy)
10.52
2024-03-08
4
M
0
42523
35.75
D
2028-11-26
Common Stock
42523
38020
D
Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
/s/ Kelly Deck
2024-03-12